Cite
MLA Citation
L. Vinti et al.. “PHASE 2 KEYNOTE-667 STUDY OF PEMBROLIZUMAB (PEMBRO) IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (Chl) AND SLOW EARLY RESPONSE (SER) TO FRONTLINE CHEMOTHERAPY (CHEMO).” Leukemia research, vol. 121, n.d., pp. S33–S34. http://access.bl.uk/ark:/81055/vdc_100168583934.0x000046